[Real-world study on the efficacy and safety of first-line antiviral therapy for chronic hepatitis B].

医学 恩替卡韦 内科学 病毒血症 替诺福韦-阿拉芬酰胺 胃肠病学 乙型肝炎 病毒载量 慢性肝炎 免疫学 拉米夫定 抗逆转录病毒疗法 病毒
作者
C D Chang,Chang Dong,Suxian Zhao,Xiwei Yuan,X X Zhang,Dandan Zhao,Yu Dou,Yuemin Nan
出处
期刊:PubMed 卷期号:31 (8): 855-861
标识
DOI:10.3760/cma.j.cn501113-20230322-00124
摘要

Objective: To clarify the clinical efficacy of first-line oral antiviral drugs tenofovir alafenamide (TAF), tenofovir disoproxil fumarate (TDF), and entecavir (ETV) in the treatment of chronic hepatitis B (CHB) and their safety profiles with lipid, bone, and kidney metabolism. Methods: 458 CHB cases diagnosed and treated at the Department of Hepatology of Integrated Traditional Chinese and Western Medicine of the Third Hospital of Hebei Medical University from February 2010 to November 2022 were selected. TAF (175 cases), TDF (124 cases), and ETV (159 cases) were used as therapies. At 24 and 48 weeks, the virology, biochemical response, changes in liver stiffness measurement (LSM), and bone, kidney, and blood lipid metabolism safety profiles were compared and analyzed. Results: After 24 and 48 weeks of TAF, TDF, and ETV therapy, HBV DNA load decreased by 3.28, 2.69, and 3.14 log10 IU/ml and 3.28, 2.83, and 3.65 log10 IU/ml, respectively, compared with the baseline, and the differences between the three groups were statistically significant, P < 0.001. The complete virological response rates were 73.95%, 66.09%, 67.19%, and 82.22%, 72.48%, and 70.49%, respectively. The incidence rates of low-level viremia were 16.67%, 21.70%, and 23.08%, while poor response rates were 1.11%, 3.67%, and 4.10%. ALT normalization rates were 64.00%, 63.89%, 67.96%, and 85.33%, 80.56%, 78.64%, respectively, and there was no statistically significant difference among the groups. LSM was significantly improved in patients treated with TAF for 48 weeks, P = 0.022. Serum phosphorus level gradually decreased with the prolongation of TDF treatment. The TAF treatment group had a good safety profile for kidney, bone, and phosphorus metabolism, with no dyslipidemia or related occurrences of risk. Conclusion: There are some differences in the therapeutic effects of first-line anti-HBV drugs. TAF has the lowest incidence of low-level viremia after 48 weeks of treatment and has a good safety profile in kidney, bone, and blood lipid metabolism.目的: 明确一线口服抗病毒药物富马酸丙酚替诺福韦(TAF)、富马酸替诺福韦二吡呋酯(TDF)及恩替卡韦(ETV)治疗慢性乙型肝炎(CHB)的临床效果和脂质代谢、骨骼、肾脏的安全性。 方法: 选择2010年2月至2022年11月河北医科大学第三医院中西医结合肝病科诊治的CHB 458例,分别采用TAF(175例)、TDF(124例)和ETV(159例)治疗,对比分析24、48周病毒学、生化学应答、肝脏硬度值(LSM)变化及骨骼、肾脏、血脂安全性。 结果: TAF、TDF、ETV治疗24、48周,HBV DNA载量分别较基线降低3.28、2.69、3.14 log(10) IU/ml和3.28、2.83、3.65 log(10) IU/ml,均较基线显著降低,3组间比较,差异均有统计学意义,P值均< 0.001;完全病毒学应答率依次为73.95%、66.09%、67.19%和82.22%、72.48%、70.49%;低病毒血症发生率为16.67%、21.70%、23.08%,应答不佳率依次为1.11%、3.67%、4.10%;ALT复常率依次为64.00%、63.89%、67.96%和85.33%、80.56%、78.64%,各组间差异无统计学意义。TAF治疗48周患者LSM显著改善,P = 0.022。随TDF治疗时间延长,血清磷水平逐渐降低,TAF治疗组肾脏、骨骼、磷代谢安全性好,未出现血脂异常及相关风险。 结论: 一线抗乙型肝炎病毒药物的治疗效果存在一定差异,TAF治疗48周低病毒血症发生率最低,肾脏、骨骼及血脂安全性好。.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
认真宛发布了新的文献求助10
刚刚
伶俐鸽子发布了新的文献求助10
1秒前
科学家发布了新的文献求助10
2秒前
方大完成签到 ,获得积分10
2秒前
可爱的函函应助Yola采纳,获得10
3秒前
sun发布了新的文献求助10
3秒前
tsm完成签到,获得积分10
3秒前
Parsifal完成签到,获得积分10
4秒前
香蕉觅云应助终陌采纳,获得10
4秒前
木木完成签到,获得积分10
6秒前
111完成签到,获得积分10
6秒前
Xiao10105830完成签到,获得积分10
6秒前
obaica完成签到,获得积分10
7秒前
7秒前
7秒前
不安的可乐完成签到,获得积分10
8秒前
iffy完成签到,获得积分10
8秒前
夜宵完成签到,获得积分10
9秒前
乐只完成签到,获得积分10
9秒前
LLL完成签到 ,获得积分10
9秒前
量子星尘发布了新的文献求助10
9秒前
嘟嘟喂嘟嘟应助朴实的杰采纳,获得10
9秒前
ccc给ccc的求助进行了留言
9秒前
冰刀完成签到,获得积分10
9秒前
mzc发布了新的文献求助10
10秒前
sunnyqqz完成签到,获得积分10
10秒前
大恩区完成签到,获得积分10
10秒前
Egoist完成签到,获得积分10
11秒前
11秒前
12秒前
LZQ921完成签到,获得积分10
12秒前
盘尼西林发布了新的文献求助10
12秒前
zkkz完成签到,获得积分10
12秒前
随风走完成签到,获得积分10
12秒前
zz发布了新的文献求助10
13秒前
Migrol完成签到,获得积分10
13秒前
小杨发布了新的文献求助10
13秒前
十四应助大地采纳,获得10
14秒前
小科完成签到,获得积分10
14秒前
总之完成签到 ,获得积分10
15秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Social Research Methods (4th Edition) by Maggie Walter (2019) 2390
A new approach to the extrapolation of accelerated life test data 1000
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4009004
求助须知:如何正确求助?哪些是违规求助? 3548719
关于积分的说明 11299835
捐赠科研通 3283284
什么是DOI,文献DOI怎么找? 1810333
邀请新用户注册赠送积分活动 886115
科研通“疑难数据库(出版商)”最低求助积分说明 811259